The Yin and Yang of protein folding

FEBS Journal

Volumn 272, Issue 23, 2005, Pages 5962-5970

  Jahn, Thomas R ^a   Radford, Sheena E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Amyloid fibril formation; Energy landscapes; Intermediates; Misfolding; Protein folding

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; CREUTZFELDT JAKOB DISEASE; ENERGY TRANSFER; HUMAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; SHORT SURVEY; SURFACE PROPERTY; THEORETICAL STUDY;

AMYLOIDOSIS; ENERGY METABOLISM; HUMANS; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 28244437028     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.05021.x     Document Type: Short Survey

References (64)

1. Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181, 223-230.
2. Vendruscolo M & Dobson CM (2005) Towards complete descriptions of the free-energy landscapes of proteins. Philos Transact A Math Phys Eng Sci 363, 433-450; discussion 450-452.
3. Stefani M (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 1739, 5-25.
4. Wolynes PG (2005) Energy landscapes and solved protein-folding problems. Philos Transact A Math Phys Eng Sci 363, 453-464; discussion 464-467.
5. Daggett V & Fersht AR (2003) Is there a unifying mechanism for protein folding? Trends Biochem Sci 28, 18-25.
6. Fersht AR (2000) Transition-state structure as a unifying basis in protein-folding mechanisms: contact order, chain topology, stability, and the extended nucleus mechanism. Proc Natl Acad Sci USA 97, 1525-1529.
7. Lindorff-Larsen K, Rogen P, Paci E, Vendruscolo M & Dobson CM (2005) Protein folding and the organization of the protein topology universe. Trends Biochem Sci 30, 13-19.
8. Vendruscolo M, Paci E, Dobson CM & Karplus M (2001) Three key residues form a critical contact network in a protein folding transition state. Nature 409, 641-645.
9. Kubelka J, Hofrichter J & Eaton WA (2004) The protein folding 'speed limit'. Curr Opin Struct Biol 14, 76-88.
10. Haustein E & Schwille P (2004) Single-molecule spectroscopic methods. Curr Opin Struct Biol 14, 531-540.
11. Fersht AR & Sato S (2004) Phi-value analysis and the nature of protein-folding transition states. Proc Natl Acad Sci USA 101, 7976-7981.
12. Shea JE & Brooks CL III (2001) From folding theories to folding proteins: a review and assessment of simulation studies of protein folding and unfolding. Annu Rev Phys Chem 52, 499-535.
13. Fersht AR & Daggett V (2002) Protein folding and unfolding at atomic resolution. Cell 108, 573-582.
14. Vendruscolo M, Paci E, Karplus M & Dobson CM (2003) Structures and relative free energies of partially folded states of proteins. Proc Natl Acad Sci USA 100, 14817-14821.
15. Bollen YJ, Sanchez IE & van Mierlo CP (2004) Formation of on- and off-pathway intermediates in the folding kinetics of Azotobacter vinelandii apoflavodoxin. Biochemistry 43, 10475-10489.
16. Capaldi AP, Shastry MC, Kleanthous C, Roder H & Radford SE (2001) Ultrarapid mixing experiments reveal that Im7 folds via an on-pathway intermediate. Nat Struct Biol 8, 68-72.
17. Radford SE, Dobson CM & Evans PA (1992) The folding of hen lysozyme involves partially structured intermediates and multiple pathways. Nature 358, 302-307.
18. Baram D & Yonath A (2005) From peptide-bond formation to cotranslational folding: dynamic, regulatory and evolutionary aspects. FEBS Lett 579, 948-954.
19. Dyson HJ & Wright PE (2004) Unfolded proteins and protein folding studied by NMR. Chem Rev 104, 3607-3622.
20. Korzhnev DM, Salvatella X, Vendruscolo M, Di Nardo AA, Davidson AR, Dobson CM & Kay LE (2004) Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR. Nature 430, 586-590.
21. Sipe JD & Cohen AS (2000) Review: history of the amyloid fibril. J Struct Biol 130, 88-98.
22. Sunde M & Blake C (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50, 123-159.
23. Tycko R (2004) Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol 14, 96-103.
24. Guijarro JI, Sunde M, Jones JA, Campbell ID & Dobson CM (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 95, 4224-4228.
25. Buxbaum JN (2003) Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases? Trends Biochem Sci 28, 585-592.
26. Uversky VN & Fink AL (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698, 131-153.
27. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426, 900-904.
28. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CC, et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787-793.
29. Hammarstrom P, Jiang X, Hurshman AR, Powers ET & Kelly JW (2002) Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci USA 99 (Suppl. 4), 16427-16432.
30. Jahn TR & Radford SE (2005) Beta-2-Microglobulin. In Amyloid Proteins: the Beta Sheet Conformation and Diseases (Sipe JD, ed.), pp. 667-695. Wiley-VCH, Weinheim.
31. Der-Sarkissian A, Jao CC, Chen J & Langen R (2003) Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling. J Biol Chem 278, 37530-37535.
32. Kleizen B & Braakman I (2004) Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol 16, 343-349.
33. Young JC, Agashe VR, Siegers K & Hartl FU (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5, 781-791.
34. Maier T, Ferbitz L, Deuerling E & Ban N (2005) A cradle for new proteins: trigger factor at the ribosome. Curr Opin Struct Biol 15, 204-212.
35. Pickart CM & Cohen RE (2004) Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 5, 177-187.
36. Barral JM, Broadley SA, Schaffar G & Hartl FU (2004) Roles of molecular chaperones in protein misfolding diseases. Semin Cell Dev Biol 15, 17-29.
37. Lashuel HA, Hartley D, Petre BM, Walz T & Lansbury PT Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291.
38. Gosal WS, Morten IJ, Hewitt EW, Smith DA, Thomson NH & Radford SE. (2005) Competing pathways determine fibril morphology in the self-assembly of beta-2-microglobulin into amyloid. J Mol Biol 351, 850-864.
39. Caughey B & Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26, 267-298.
40. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM & Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
41. Wacker JL, Zareie MH, Fong H, Sarikaya M & Muchowski PJ (2004) Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat Struct Mol Biol 11, 1215-1222.
42. Muchowski PJ (2002) Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 35, 9-12.
43. Lee S, Sowa ME, Choi JM & Tsai FT (2004) The ClpB/Hsp104 molecular chaperone - a protein disaggregating machine. J Struct Biol 146, 99-105.
44. Forman MS, Trojanowski JQ & Lee VM (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10, 1055-1063.
45. Hammarstrom P, Wiseman RL, Powers ET & Kelly JW (2003) Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299, 713-716.
46. Dumoulin M, Last AM, Desmyter A, Decanniere K, Canet D, Larsson G, Spencer A, Archer DB, Sasse J, Muyldermans S, et al. (2003) A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 424, 783-788.
47. Alexandrescu AT (2005) Amyloid accomplices and enforcers. Protein Sci 14, 1-12.
48. Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C et al. (2002) Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417, 254-259.
49. Kisilevsky R, Szarek WA, Ancsin J, Vohra R, Li Z & Marone S (2004) Novel glycosaminoglycan precursors as antiamyloid agents: Part IV. J Mol Neurosci 24, 167-172.
50. Rochet JC & Lansbury PT Jr (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10, 60-68.
51. Chiti F, Taddei N, Baroni F, Capanni C, Stefani M, Ramponi G & Dobson CM (2002) Kinetic partitioning of protein folding and aggregation. Nat Struct Biol 9, 137-143.
52. Lopez de la Paz M & Serrano L (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 101, 87-92.
53. Chili F, Stefani M, Taddei N, Ramponi G & Dobson CM (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424, 805-808.
54. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J & Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22, 1302-1306.
55. Wigley WC, Corboy MJ, Cutler TD, Thibodeau PH, Oldan J, Lee MG, Rizo J, Hunt JF & Thomas PJ (2002) A protein sequence that can encode native structure by disfavoring alternate conformations. Nat Struct Biol 9, 381-388.
56. Richardson JS & Richardson DC (2002) Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 99, 2754-2759.
57. Clark PL (2004) Protein folding in the cell: reshaping the folding funnel. Trends Biochem Sci 29, 527-534.
58. Coyle JE, Texter FL, Ashcroft AE, Masselos D, Robinson CV & Radford SE (1999) GroEL accelerates the refolding of hen lysozyme without changing its folding mechanism. Nat Struct Biol 6, 683-690.
59. Brinker A, Pfeifer G, Kerner MJ, Naylor DJ, Hartl FU & Hayer-Hartl M (2001) Dual function of protein confinement in chaperonin-assisted protein folding. Cell 107, 223-233.
60. Jewett AI, Baumketner A & Shea JE (2004) Accelerated folding in the weak hydrophobic environment of a chaperonin cavity: creation of an alternate fast folding pathway. Proc Natl Acad Sci USA 101, 13192-13197.
61. Sekijima Y, Wiseman RL, Matteson J, Hammarstrom P, Miller SR, Sawkar AR, Balch WE & Kelly JW (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121, 73-85.
62. Nguyen HD & Hall CK (2004) Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 101, 16180-16185.
63. DeMarco ML & Daggett V (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci USA 101, 2293-2298.
64. Dobson CM (2004) Experimental investigation of protein folding and misfolding. Methods 34, 4-14.